Aquestive Therapeutics (AQST) PT Lowered to $9 at BMO Capital
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Price: $5.38 +2.67%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 12
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 12
Join SI Premium – FREE
BMO Capital analyst Gary Nachman lowered the price target on Aquestive Therapeutics (NASDAQ: AQST) to $9.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Upgrades Coal India Ltd (COAL:IN) to Buy
- HP Enterprise (HPE) PT Raised to $79 at Barclays
- Snowflake Inc. (SNOW) PT Raised to $384 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
